Recro Pharma, Inc., a CDMO dedicated to solving complex formulation and manufacturing challenges for oral solid dose drugs, has signed a development and cGMP manufacturing agreement with a new client to provide early-stage development and manufacturing services to support the client’s ongoing clinical development of an orally administered, minimally-absorbed investigational compound. “The opportunity to support our new client’s clinical development of its novel therapeutic candidate allows Re...